Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
30
result was found. Results that relate to
Rapid health technology assessment
Efgartigimod alfa in the treatment of generalized myasthenia gravis: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1156-1163.
12199 times
2409 times
HUANG Gerile
LI Yujie
ZHANG Wenjing
GUO Hao
Efgartigimod alfa
Myasthenia gravis
Rapid health technology assessment
Efficaey
Safety
Economy
Details
Tofacitinib for the treatment of ulcerative colitis: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(12):1414-1424.
18415 times
2211 times
LI Huiling
DUAN Yinyin
LI Qianqian
WU Xiaoli
Tofacitinib
Ulcerative colitis
Rapid health technology assessment
Details
Vonoprazan for ulcers associated with endoscopic submucosal dissection: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(3):306-313.
11667 times
2048 times
WANG Wei
KE Yijun
CHENG Chang
FANG Chongwen
PAN Lisheng
JIN Yong
ZHANG Yanping
Vonoprazan
Endoscopic submucosal dissection
Ulcer
Rapid health technology assessment
Details
Venetoclax in the treatment of non-M3 acute myeloid leukemia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(3):314-323.
12738 times
1959 times
ZHANG Yazhuo
LI Huiling
Duan Yinyin
SHI Yuye
Venetoclax
Non-M3 acute myeloid leukemia
Rapid health technology assessment
Details
Dorzagliatin in the treatment of type 2 diabetes:a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(4):448-455.
19326 times
3592 times
LI Yujie
ZHANG Wenjing
YANG Hongxin
GUO Hao
Dorzagliatin
Type 2 diabetes mellitus
Rapid health technology assessment
Efficacy
Safety
Economy
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(7):806-814.
11263 times
1817 times
HOU Yibing
KANG Shuo
GONG Yuan
WANG Xiaohui
NIE Ying
LIU Huanlong
Sugemalimab
Non-small cell lung cancer
Effectiveness
Safety
Economics
Rapid health technology assessment
Details
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(9):1057-1065.
16370 times
2224 times
ZHANG Yunxuan
ZHOU Haifeng
GAO Ningzhou
WU Jianbo
QIAN Cheng
ZHANG Min
GUO Han
SONG Zhongjuan
LIU Xiaoyan
Tirzepatide
Type 2 diabetes mellitus
Rapid health technology assessment
Efficacy
Safety
Cost-effectiveness
Details
Inclisiran in the treatment of dyslipidemia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(10):1198-1205.
8508 times
1642 times
CHEN Lingbin
PAN Weiping
CHEN Zhou
XU Wentan
Inclisiran
Dyslipidemia
Efficacy
Safety
Cost-effectiveness
Rapid health technology assessment
Details
Rapid health technology assessment of linezolid for the treatment of complicated lower respiratory tract infections
Published on
Frontiers in Pharmaceutical Sciences
2025,29(10):1731-1737.
6559 times
1149 times
LANG Yan
PAN Jiahui
WANG Ling
Linezolid
Lower respiratory tract infection
Rapid health technology assessment
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(11):1302-1310.
6426 times
1264 times
YANG Shou
NIE Ying
GONG Yuan
KANG Shuo
HOU Yibing
WANG Xiaohui
PAN Zhenhua
Toripalimab
Advanced esophageal cancer
Rapid health technology assessment
Effectiveness
Safety
Economy
Details
Rapid health technology assessment of avatrombopag for the treatment of primary immune thrombocytopenia in adults
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(11):1311-1319.
8043 times
1303 times
LI Zhou
LING Ya
ZHANG Jie
ZHU Ling
Avatrombopag
Primary immune thrombocytopenia
Efficacy
Safety
Economy
Rapid health technology assessment
Details
Rapid health technology assessment of crisaborole in the treatment of mild-to-moderate atopic dermatitis
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(12):1423-1433.
6367 times
1096 times
ZHANG Jinfen
TONG Ruofei
YANG Lin
SUN Yanyan
Crisaborole
Atopic dermatitis
Rapid health technology assessment
Efficacy
Safety
Economy
Details
Oliceridine injection for postoperative analgesia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(12):1434-1440.
4657 times
1011 times
ZHOU Jing
LUO Hao
ZHENG Xiaoke
CAI Jingyue
XIE Caipeng
TAN Qiuhua
Oliceridine
Postoperative analgesia
Efficacy
Safety
Economy
Rapid health technology assessment
Details
Rapid health technology assessment of PARP inhibitors in the treatment of recurrent ovarian cancer
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(4):439-450.
2900 times
661 times
LI Anna
LI Jianping
CHEN Wenjun
ZUO Jing
HUANG Xiaolu
MENG Jun
Poly ADP ribose polymerase inhibitors
Recurrent ovarian cancer
Rapid health technology assessment
Efficacy
Safety
Economy
Details
Rapid health technology assessment of donanemab in the treatment of Alzheimer's disease
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):800-809.
1044 times
308 times
FAN Liming
DENG Tiantian
LAN Haiyue
DONG Yafen
QIU Yan
WANG Jian
Donanemab
Alzheimer's disease
Efficacy
Safety
Cost-effectiveness
Rapid health technology assessment
Details
上一页
1
2